Andilum, Baby Girl .

HRN: 21-99-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2022
CEFTAZIDIME 1GM (VIAL)
09/23/2022
09/29/2022
IV
27mg
Q12
Neonatal Sepsis
Waiting Final Action 
09/26/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/26/2022
10/09/2022
IV
5.4mg
Q48
Neonatal Sepsis
Waiting Final Action 
09/27/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/27/2022
10/04/2022
IV
90mg
Q12
Neonatal Sepsis
Waiting Final Action 
10/18/2022
FLUCONAZOLE 50MG (CAP)
10/18/2022
10/25/2022
PO
4.5 Mg
2 X A Week
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: